The development of modern biologics demands a paradigm shift: glycosylation must be treated as a critical design parameter, not merely a compliance checkpoint. While standard analysis can list what glycans are present, it fails to uncover how they impact your drug's specific mechanism of action. This gap necessitates a purpose-driven, program-specific strategy—a concept central...
Glycoproteins are pivotal in disease development, how the immune system reacts to pathogens and cellular communication. For this reason, they are particularly important targets for biomarker discovery and new therapies. However, scientists have historically faced substantial challenges in their analysis due to their scarcity, heterogeneous structural nature, and the complexity of their...
Pro Benefits
О нас
Условия использования
Конфиденциальность
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
